ReviewFrontiers in pharmacology2023

Management and prediction of immune-related adverse events for PD1/PDL-1 immunotherapy in colorectal cancer.

Liting Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.